Latest news
Long Shortz with Neurizon Therapeutics: Milestones stack up for ALS program - NT NewsNT News · Tue, 04 Aug 2026 16:07:00 GMTNeurizon advances ALS trial in Q4 FY26 - The AustralianThe Australian · Tue, 04 Aug 2026 03:12:00 GMTNeurizon secures up to $17.5 million in non-dilutive R&D financing - BiotechDispatchBiotechDispatch · Mon, 03 Aug 2026 23:09:40 GMTNeurizon Secures Up to $17.5 Million Non-Dilutive R&D Financing Facility with Dare Capital - kalkine.com.aukalkine.com.au · Fri, 31 Jul 2026 07:00:00 GMTNeurizon Therapeutics Secures $17.5 Million Non-Dilutive R&D Funding Facility with Dare Capital - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTNeurizon accelerates ALS trial and secures supply deal as funding base strengthens - TipRanksTipRanks · Fri, 31 Jul 2026 06:08:28 GMTNeurizon Secures $17.5m Non-Dilutive R&D Financing to Fund ALS Trial - TipRanksTipRanks · Fri, 31 Jul 2026 05:41:24 GMT